Advertisement

Testing the Timing: Time Factor in Radiation Treatment for Head and Neck Cancers

  • Muhammad M. Fareed
  • Rizwan Ishtiaq
  • Thomas J. Galloway
Head and Neck Cancer (L Licitra, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Head and Neck Cancer

Opinion statement

Overall radiation treatment time has long been recognized as an important factor in head and neck tumor control. The concern of tumor growth in waiting time either before starting radiotherapy or during treatment is substantial given its negative impact on clinical outcome. There is an overwhelming evidence that increasing the time to initiate treatment increases the tumor burden and worsens the prognosis. This effect is more pronounced especially in patients with an early stage cancer disease. Delay in treatment initiation is contributed by both health care- and patient-related factors. Health care-related factors include advancement in diagnostic modalities and transfer of patient to academic health care centers accompanied by delayed referrals and long-awaited appointments. Patient-related factors include delayed reporting time and socioeconomic factors. An efficient transition of care along with access of cancer care modalities to community health care centers will not only improve the quality of care in secondary health care centers but also help decrease the patient burden in tertiary centers. A quick and well-structured multidisciplinary appointment program is fundamental in shortening the time required for patient referrals, thus increasing the optimal survival time for Head and Neck cancer patients with early initiation of treatment.

Keywords

Head and neck cancers Time to treatment initiation Treatment package time Radiation treatment time Radiation therapy 

Notes

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Overgaard J, Alsner J, Eriksen J, Horsman MR, Grau C. Importance of overall treatment time for the response to radiotherapy in patients with squamous cell carcinoma of the head and neck. Rays. 2000;25(3):313–9.PubMedGoogle Scholar
  2. 2.
    Mackillop WJ, Zhou S, Groome P, Dixon P, Cummings BJ, Hayter C, et al. Changes in the use of radiotherapy in Ontario 1984–1995. Int J Radiat Oncol Biol Phys. 1999;44(2):355–62.PubMedCrossRefGoogle Scholar
  3. 3.
    Klausen OG, Olofsson J, Rosengren B. [A long waiting time for radiotherapy. Not acceptable for patients with neoplasms]. Tidsskrift for den Norske laegeforening: tidsskrift for praktisk medicin, ny raekke 1989;109 (23):2324–5.Google Scholar
  4. 4.
    Ash D, Barrett A, Hinks A, Squire C. Royal College of R. Re-audit of radiotherapy waiting times 2003. Clin Oncol. 2004;16(6):387–94.CrossRefGoogle Scholar
  5. 5.
    Denham JW, Hamilton CS, Joseph DJ. How should a waiting list for treatment be managed? Australas Radiol. 1992;36(3):274–5.PubMedCrossRefGoogle Scholar
  6. 6.
    Esco R, Palacios A, Pardo J, Biete A, Carceller JA, Veiras C, et al. Infrastructure of radiotherapy in Spain: a minimal standard of radiotherapy resources. Int J Radiat Oncol Biol Phys. 2003;56(2):319–27.PubMedCrossRefGoogle Scholar
  7. 7.
    Gabriele P, Malinverni G, Bona C, Manfredi M, Delmastro E, Gatti M, et al. Are quality indicators for radiotherapy useful in the evaluation of service efficacy in a new based radiotherapy institution? Tumori. 2006;92(6):496–502.PubMedGoogle Scholar
  8. 8.
    Jensen AR, Nellemann HM, Overgaard J. Tumor progression in waiting time for radiotherapy in head and neck cancer. Radiother Oncol. 2007;84(1):5–10.PubMedCrossRefGoogle Scholar
  9. 9.
    Mackillop WJ, Fu H, Quirt CF, Dixon P, Brundage M, Zhou Y. Waiting for radiotherapy in Ontario. Int J Radiat Oncol Biol Phys. 1994;30(1):221–8.PubMedCrossRefGoogle Scholar
  10. 10.
    Schafer C, Nelson K, Herbst M. Waiting for radiotherapy a national call for ethical discourse on waiting lists in radiotherapy: findings from a preliminary survey. Strahlentherapie und Onkologie. 2005;181(1):9–19.PubMedCrossRefGoogle Scholar
  11. 11.
    Waaijer A, Terhaard CH, Dehnad H, Hordijk GJ, van Leeuwen MS, Raaymakers CP, et al. Waiting times for radiotherapy: consequences of volume increase for the TCP in oropharyngeal carcinoma. Radiother Oncol. 2003;66(3):271–6.PubMedCrossRefGoogle Scholar
  12. 12.
    Mackillop WJ, Bates JH, O’Sullivan B, Withers HR. The effect of delay in treatment on local control by radiotherapy. Int J Radiat Oncol Biol Phys. 1996;34(1):243–50.PubMedCrossRefGoogle Scholar
  13. 13.
    Webb S, Nahum AE. A model for calculating tumour control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol. 1993;38(6):653–66.PubMedCrossRefGoogle Scholar
  14. 14.
    Fortin A, Bairati I, Albert M, Moore L, Allard J, Couture C. Effect of treatment delay on outcome of patients with early-stage head-and-neck carcinoma receiving radical radiotherapy. Int J Radiat Oncol Biol Phys. 2002;52(4):929–36.PubMedCrossRefGoogle Scholar
  15. 15.
    •• Murphy CT, Galloway TJ, Handorf EA, Egleston BL, Wang LS, Mehra R, et al. Survival impact of increasing time to treatment initiation for patients with head and neck cancer in the United States. J Clin Oncol. 2016;34(2):169–78. A large database study showing that prolonged time to treatment initiation is affecting survival in head and neck cancer patients, with more than 60 days being consistently detrimental.PubMedCrossRefGoogle Scholar
  16. 16.
    Bietendorf J. FDG PET reimbursement. J Nuclear Med Technol. 2004;32(1):33–8.Google Scholar
  17. 17.
    Cacicedo J, Fernandez I, Del Hoyo O, Dolado A, Gomez-Suarez J, Hortelano E, et al. Should PET/CT be implemented in the routine imaging work-up of locally advanced head and neck squamous cell carcinoma? A prospective analysis. Eur J Nucl Med Mol Imaging. 2015;42(9):1378–89.PubMedCrossRefGoogle Scholar
  18. 18.
    Lonneux M, Hamoir M, Reychler H, Maingon P, Duvillard C, Calais G, et al. Positron emission tomography with [18F]fluorodeoxyglucose improves staging and patient management in patients with head and neck squamous cell carcinoma: a multicenter prospective study. J Clin Oncol Off J Am Soc Clin Oncol. 2010;28(7):1190–5.CrossRefGoogle Scholar
  19. 19.
    Dinan MA, Curtis LH, Hammill BG, Patz EF Jr, Abernethy AP, Shea AM, et al. Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999–2006. JAMA. 2010;303(16):1625–31.PubMedCrossRefGoogle Scholar
  20. 20.
    Chaturvedi AK, Engels EA, Pfeiffer RM, Hernandez BY, Xiao W, Kim E, et al. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol Off J Am Soc Clin Oncol. 2011;29(32):4294–301.CrossRefGoogle Scholar
  21. 21.
    Wuthrick EJ, Zhang Q, Machtay M, Rosenthal DI, Nguyen-Tan PF, Fortin A, et al. Institutional clinical trial accrual volume and survival of patients with head and neck cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2015;33(2):156–64.CrossRefGoogle Scholar
  22. 22.
    Murphy CT, Galloway TJ, Handorf EA, Wang L, Mehra R, Flieder DB, et al. Increasing time to treatment initiation for head and neck cancer: an analysis of the National Cancer Database. Cancer. 2015;121(8):1204–13.PubMedCrossRefGoogle Scholar
  23. 23.
    Smith BD, Haffty BG, Wilson LD, Smith GL, Patel AN, Buchholz TA. The future of radiation oncology in the United States from 2010 to 2020: will supply keep pace with demand? J Clin Oncol Off J Am Soc Clin Oncol. 2010;28(35):5160–5.CrossRefGoogle Scholar
  24. 24.
    Chen AY, Fedewa S, Pavluck A, Ward EM. Improved survival is associated with treatment at high-volume teaching facilities for patients with advanced stage laryngeal cancer. Cancer. 2010;116(20):4744–52.PubMedCrossRefGoogle Scholar
  25. 25.
    Mell LK, Mehrotra AK, Mundt AJ. Intensity-modulated radiation therapy use in the U.S., 2004. Cancer. 2005;104(6):1296–303.PubMedCrossRefGoogle Scholar
  26. 26.
    Ezzell GA, Galvin JM, Low D, Palta JR, Rosen I, Sharpe MB, et al. Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee. Med Phys. 2003;30(8):2089–115.PubMedCrossRefGoogle Scholar
  27. 27.
    Guizard AV, Dejardin O, Launay L, Bara S, Lapotre-Ledoux B, Babin E, et al. What are the real waiting times for therapeutic management of head and neck cancer: a study in the general population in the north-west of France. Eur Arch Otorhinolaryngol. 2016;273(11):3951–8.PubMedCrossRefGoogle Scholar
  28. 28.
    •• Sharma S, Bekelman J, Lin A, Lukens JN, Roman BR, Mitra N, et al. Clinical impact of prolonged diagnosis to treatment interval (DTI) among patients with oropharyngeal squamous cell carcinoma. Oral Oncol. 2016;56:17–24. NCDB study demonstrating socioeconomic status, academic setting, high volume, and IMRT as factors associated with increased diagnosis to treatment interval, correlating with survival outcomes.PubMedPubMedCentralCrossRefGoogle Scholar
  29. 29.
    Toto JM, Chang EI, Agag R, Devarajan K, Patel SA, Topham NS. Improved operative efficiency of free fibula flap mandible reconstruction with patient-specific, computer-guided preoperative planning. Head Neck. 2015;37(11):1660–4.PubMedCrossRefGoogle Scholar
  30. 30.
    Wallace CG, Chang YM, Tsai CY, Wei FC. Harnessing the potential of the free fibula osteoseptocutaneous flap in mandible reconstruction. Plast Reconstr Surg. 2010;125(1):305–14.PubMedCrossRefGoogle Scholar
  31. 31.
    Stitzenberg KB, Wong YN, Nielsen ME, Egleston BL, Uzzo RG. Trends in radical prostatectomy: centralization, robotics, and access to urologic cancer care. Cancer. 2012;118(1):54–62.PubMedCrossRefGoogle Scholar
  32. 32.
    Yu X, Lum D, Kiet TK, Fuh KC, Orr J Jr, Brooks RA, et al. Utilization of and charges for robotic versus laparoscopic versus open surgery for endometrial cancer. J Surg Oncol. 2013;107(6):653–8.PubMedCrossRefGoogle Scholar
  33. 33.
    Brouha XD, Tromp DM, Koole R, Hordijk GJ, Winnubst JA, de Leeuw JR. Professional delay in head and neck cancer patients: analysis of the diagnostic pathway. Oral Oncol. 2007;43(6):551–6.PubMedCrossRefGoogle Scholar
  34. 34.
    Teppo H, Alho OP. Comorbidity and diagnostic delay in cancer of the larynx, tongue and pharynx. Oral Oncol. 2009;45(8):692–5.PubMedCrossRefGoogle Scholar
  35. 35.
    Seoane J, Takkouche B, Varela-Centelles P, Tomas I, Seoane-Romero JM. Impact of delay in diagnosis on survival to head and neck carcinomas: a systematic review with meta-analysis. Clin Otolaryngol. 2012;37(2):99–106.PubMedCrossRefGoogle Scholar
  36. 36.
    Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med. 2010;363(1):24–35.PubMedPubMedCentralCrossRefGoogle Scholar
  37. 37.
    Bilimoria KY, Ko CY, Tomlinson JS, Stewart AK, Talamonti MS, Hynes DL, et al. Wait times for cancer surgery in the United States: trends and predictors of delays. Ann Surg. 2011;253(4):779–85.PubMedCrossRefGoogle Scholar
  38. 38.
    Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB. Regional lymph node involvement and its significance in the development of distant metastases in head and neck carcinoma. Cancer. 1993;71(2):452–6.PubMedCrossRefGoogle Scholar
  39. 39.
    Leemans CR, Tiwari R, Nauta JJ, van der Waal I, Snow GB. Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor. Cancer. 1994;73(1):187–90.PubMedCrossRefGoogle Scholar
  40. 40.
    Kowalski LP, Carvalho AL. Influence of time delay and clinical upstaging in the prognosis of head and neck cancer. Oral Oncol. 2001;37(1):94–8.PubMedCrossRefGoogle Scholar
  41. 41.
    van Harten MC, Hoebers FJ, Kross KW, van Werkhoven ED, van den Brekel MW, van Dijk BA. Determinants of treatment waiting times for head and neck cancer in the Netherlands and their relation to survival. Oral Oncol. 2015;51(3):272–8.PubMedCrossRefGoogle Scholar
  42. 42.
    Schrijvers CT, Coebergh JW, Mackenbach JP. Socioeconomic status and comorbidity among newly diagnosed cancer patients. Cancer. 1997;80(8):1482–8.PubMedCrossRefGoogle Scholar
  43. 43.
    Siciliani L, Verzulli R. Waiting times and socioeconomic status among elderly Europeans: evidence from SHARE. Health Econ. 2009;18(11):1295–306.PubMedCrossRefGoogle Scholar
  44. 44.
    Naghavi AO, Echevarria MI, Grass GD, Strom TJ, Abuodeh YA, Ahmed KA, et al. Having Medicaid insurance negatively impacts outcomes in patients with head and neck malignancies. Cancer. 2016.Google Scholar
  45. 45.
    Albano JD, Ward E, Jemal A, Anderson R, Cokkinides VE, Murray T, et al. Cancer mortality in the United States by education level and race. J Natl Cancer Inst. 2007;99(18):1384–94.PubMedCrossRefGoogle Scholar
  46. 46.
    Shavers VL, Harlan LC, Winn D, Davis WW. Racial/ethnic patterns of care for cancers of the oral cavity, pharynx, larynx, sinuses, and salivary glands. Cancer Metastasis Rev. 2003;22(1):25–38.PubMedCrossRefGoogle Scholar
  47. 47.
    Rosenthal DI, Mohamed ASR, Garden AS, Morrison WH, El-Naggar AK, Kamal M, et al. Final report of a prospective randomized trial to evaluate the dose-response relationship for postoperative radiation therapy and pathologic risk groups in patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2017;98(5):1002-11.PubMedCrossRefGoogle Scholar
  48. 48.
    Vikram B, Strong EW, Shah J, Spiro RH. Elective postoperative radiation therapy in stages III and IV epidermoid carcinoma of the head and neck. Am J Surg. 1980;140(4):580–4.PubMedCrossRefGoogle Scholar
  49. 49.
    Trotti A, Klotch D, Endicott J, Ridley M, Cantor A. Postoperative accelerated radiotherapy in high-risk squamous cell carcinoma of the head and neck: long-term results of a prospective trial. Head Neck. 1998;20(2):119–23.PubMedCrossRefGoogle Scholar
  50. 50.
    Chen Z, King W, Pearcey R, Kerba M, Mackillop WJ. The relationship between waiting time for radiotherapy and clinical outcomes: a systematic review of the literature. Radiother Oncol. 2008;87(1):3–16.PubMedCrossRefGoogle Scholar
  51. 51.
    Chen M, Jiang GL, Fu XL, Wang LJ, Qian H, Chen GY, et al. The impact of overall treatment time on outcomes in radiation therapy for non-small cell lung cancer. Lung Cancer. 2000;28(1):11–9.PubMedCrossRefGoogle Scholar
  52. 52.
    Fyles A, Keane TJ, Barton M, Simm J. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol. 1992;25(4):273–9.PubMedCrossRefGoogle Scholar
  53. 53.
    Kim JJ, Tannock IF. Repopulation of cancer cells during therapy: an important cause of treatment failure. Nat Rev Cancer. 2005;5(7):516–25.PubMedCrossRefGoogle Scholar
  54. 54.
    Withers HR, Taylor JM, Maciejewski B. The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol. 1988;27(2):131–46.PubMedCrossRefGoogle Scholar
  55. 55.
    Ang KK, Trotti A, Brown BW, Garden AS, Foote RL, Morrison WH, et al. Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys. 2001;51(3):571–8.PubMedCrossRefGoogle Scholar
  56. 56.
    Rosenthal DI, Liu L, Lee JH, Vapiwala N, Chalian AA, Weinstein GS, et al. Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck. Head Neck. 2002;24(2):115–26.PubMedCrossRefGoogle Scholar
  57. 57.
    • Shaikh T, Handorf EA, Murphy CT, Mehra R, Ridge JA, Galloway TJ. The impact of radiation treatment time on survival in patients with head and neck cancer. Int J Radiat Oncol Biol Phys. 2016;96(5):967–75. A large database study showing prolonged treatment time in head and neck cancers is associated with worst overall survival, even with chemoradiation.PubMedPubMedCentralCrossRefGoogle Scholar
  58. 58.
    Cannon DM, Geye HM, Hartig GK, Traynor AM, Hoang T, McCulloch TM, et al. Increased local failure risk with prolonged radiation treatment time in head and neck cancer treated with concurrent chemotherapy. Head Neck. 2014;36(8):1120–5.PubMedCrossRefGoogle Scholar
  59. 59.
    Lyhne NM, Christensen A, Alanin MC, Bruun MT, Jung TH, Bruhn MA, et al. Waiting times for diagnosis and treatment of head and neck cancer in Denmark in 2010 compared to 1992 and 2002. Eur J Cancer. 2013;49(7):1627–33.PubMedCrossRefGoogle Scholar
  60. 60.
    Brouha X, Tromp D, Hordijk GJ, Winnubst J, De Leeuw R. Role of alcohol and smoking in diagnostic delay of head and neck cancer patients. Acta Otolaryngol. 2005;125(5):552–6.PubMedCrossRefGoogle Scholar
  61. 61.
    Christophe V, Leroy T, Seillier M, Duthilleul C, Julieron M, Clisant S, et al. Determinants of patient delay in doctor consultation in head and neck cancers (Protocol DEREDIA). BMJ Open. 2014;4(7):e005286.PubMedPubMedCentralCrossRefGoogle Scholar
  62. 62.
    Tromp DM, Brouha XD, Hordijk GJ, Winnubst JA, de Leeuw JR. Patient factors associated with delay in primary care among patients with head and neck carcinoma: a case-series analysis. Fam Pract. 2005;22(5):554–9.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • Muhammad M. Fareed
    • 1
  • Rizwan Ishtiaq
    • 2
  • Thomas J. Galloway
    • 3
  1. 1.Department of Radiation OncologyDana-Farber/Brigham & Women’s Cancer Center, Harvard Medical SchoolBostonUSA
  2. 2.Beth Israel Deaconess Medical Center, Harvard Medical SchoolBostonUSA
  3. 3.Department of Radiation OncologyFox Chase Cancer CenterPhiladelphiaUSA

Personalised recommendations